Related Experiment Video
Updated: Jun 14, 2025

09:23
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
14.0K
Invasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures
Agata Zamborlin1, Francesca Pagliari2, Maria Laura Ermini3
1Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy; NEST-Scuola Normale Superiore, Piazza San Silvestro, 12, Pisa 56127, Italy.
Colloids and Surfaces. B, Biointerfaces
|September 7, 2024
Summary
New copper complex loaded hybrid nano-architectures (CuLNAs) effectively reduce glioma cell migration and invasiveness. This novel approach targets metastasis without affecting cell proliferation, offering a promising strategy for cancer treatment.
Area of Science:
- Oncology
- Nanotechnology
- Biochemistry
Background:
- Gliomas are highly lethal primary brain tumors known for recurrence and metastasis.
- Metastasis is a major cause of cancer-related death, yet effective treatments are limited.
- Copper complexes show antimetastatic potential but can disrupt copper homeostasis.
Purpose of the Study:
- To develop and evaluate copper complex loaded hybrid nano-architectures (CuLNAs) as targeted antimetastatic agents for gliomas.
- To investigate the impact of an intracellular copper source delivered via CuLNAs on glioma cell invasiveness.
Main Methods:
- Synthesis and characterization of novel CuLNAs.
- Assessment of CuLNAs' effect on glioma cell migration and proliferation.
- Analysis of epithelial-to-mesenchymal transition (EMT) gene expression.
Main Results:
- CuLNAs significantly reduced glioma cell migration compared to standard nano-architectures.
- CuLNAs did not impair glioma cell proliferation.
- Upregulation of E-cadherin and downregulation of mesenchymal genes indicated an antimigratory effect via EMT modulation.
Conclusions:
- CuLNAs represent a promising strategy for developing targeted antimetastatic agents by delivering copper intracellularly.
- Nano-architectures incorporating metal complexes offer a viable approach for creating novel antimetastatic therapies.
- This approach minimizes off-site effects by enhancing treatment localization.

